4-galactosylation

Show results for

Proteomics (43)
Unknown (31)
Genomics (3)
Metabolomics (3)
Transcriptomics (1)

Organisms

Homo sapiens (9)
Andropogon gerardi (6)
Bacteria (6)
Canis lupus familiaris (6)
Chromatiales bacterium OalgGamma1 (6)
Clavibacter nebraskensis NCPPB 2581 (6)
Cnidaria (6)
Ensifer adhaerens (6)
Fasciola (6)
Human alphaherpesvirus 1 strain 17 (6)
Human alphaherpesvirus 1 strain KOS (6)
Human betaherpesvirus 5 (6)
Human herpesvirus 2 strain 186 (6)
Mesocricetus auratus (6)
Miscanthus x giganteus (6)
Mus musculus (6)
Panicum virgatum (6)
Platyhelminthes (6)
Pseudomonas aeruginosa PA103 (6)
Rabies virus Nishigahara RCEH (6)
Rattus norvegicus (6)
Rattus rattus (6)
Rhodococcus jostii RHA1 (6)
Rhodopseudomonas palustris (6)
Sorghastrum nutans (6)
Mus musculus (2)
cellular organisms (2)
Danio rerio (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Notata (1)

Organisms

Homo sapiens (2)

Repository

MassIVE (24)
jPOST (6)
pride (6)
iProX (5)
MetaboLights (3)
geo (2)
PanoramaPublic (2)
ENA (2)

Tissue

Blood serum (2)
B cell (1)
Blood (1)
Blood cell (1)
Bone (1)
Cell culture (1)
Fat cell (1)

Disease

COVID-19 (1)
Stomach carcinoma (1)

Technology Type

Mass Spectrometry (6)
Bottom-up proteomics (3)
Mass spectrometry (2)
Shotgun proteomics (2)
Mass spectrometry assay (1)
All-ion fragmentation (1)
Data-dependent acquisition (1)

Instrument Platform

Q Exactive (6)
Orbitrap Eclipse (5)
Orbitrap Fusion Lumos (4)
Orbitrap Exploris 480 (3)
LTQ Orbitrap Elite (2)
LTQ Orbitrap Velos (2)
Matrix-assisted laser desorption-ionisation imaging MS - (2)
AB SCIEX Triple TOF 5600 (1)
LTQ Orbitrap Velos Pro (1)
Orbitrap Exploris 240 (1)
Orbitrap Fusion (1)
Q Exactive HF (1)
Q Exactive HF-X (1)
Q Exactive Plus (1)
TimsTOF (1)
TimsTOF Pro (1)
Xevo G2 Q-Tof (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)

Metabolite Name

Thr-Tyr-Asp-Arg-Asn (1)
[(2R,3S,4S,5R)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-[[(E)-2-methylbut-2-enoyl]oxymethyl]-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl (E)-2-methylbut-2-enoate (1)
[Met5,Lys6] alpha-Neo-Endorphin (1-6) (1)
Ile-Val-Ile-Phe-Asn (1)
2,4,5,6(1H,3H)-Pyrimidinetetrone,5-[2-(2-chlorophenyl)hydrazone] (1)
Bullatalicin (1)
15-deoxy--12,14-PGJ2-d4 (1)
2-docosanamidoethanesulfonic acid (1)
2,6,10,14-Tetramethyl-16-(5-methyl-3,6-dioxo-1,4-cyclohexadiene-1-yl)-2-hydroxy-6,10,14-hexadecatriene-3-one (1)
[(2S)-2-[9-(3,4-dimethyl-5-propylfuran-2-yl)nonanoyloxy]-3-hydroxypropyl] 11-(3,4-dimethyl-5-propylfuran-2-yl)undecanoate (1)
(2S,3R,4R,4aR,6aR,6bS,8aS,14bR)-2,3-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate (1)
[(2S)-2-hexadecanoyloxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] (Z)-octadec-9-enoate (1)
[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-(3-methyl-5-pentylfuran-2-yl)propanoate (1)
(2R,3R,4R,5R)-2-[(9R)-9,13-dihydroxytridecyl]-5-(hydroxymethyl)pyrrolidine-3,4-diol (1)
N-Arachidonoyl-3-hydroxy-Aminobutyric Acid (1)
(1S,4aS,10aR)-6-[(4bS,8S,8aR)-8-carboxy-2-hydroxy-4b,8-dimethyl-1-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]-7-hydroxy-1,4a-dimethyl-8-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid (1)
NCGC00384622-01_C34H42O14_(1S,2S,4S,5R,6R,7S,9R,12R)-12-Acetoxy-6-(acetoxymethyl)-2-hydroxy-2,10,10-trimethyl-5-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0~1,6~]dodecane-4,7-diyl di(3-furoate) (1)
(1'R,2R,3S,4'S,6S,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-2-butan-2-yl-21',24'-dihydroxy-12'-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one (1)
(4'Z,7'Z,10'Z,13'Z,16'Z,19'Z)-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid, diester with 1,2,3-propanetriol (1)
3-Oxolanosta-7,24Z-dien-26-oic acid (1)
[(2R,3R)-5,7-dihydroxy-2-[3,4,6-trihydroxy-5-oxo-8-[(2R,3S)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-1-yl]-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate (1)
(Gal1-4GlcNAc)2-Sp (1)
Ala-Lys-Gly-Lys-Ser (1)
DTDP-4-keto-2-deoxy-beta-L-xylose (1)
Phe-Lys-Leu-Arg (1)
Lys-Asn-Leu-Tyr-Thr (1)
Arg-Leu-Arg-Glu-Lys (1)
UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uloseuronic acid (1)
Hydrogen trioxo[3-(1lambdachromen-1-ylium-2-yl)phenoxy]-lambdasulfanuide (1)
(9R,10S,12S,13S,14R,16S,18R)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol (1)

First Public Date

2026 (1)
2020 (1)

Release Date

2025 (5)
2019 (4)
2022 (3)
2020 (3)
2018 (3)
2023 (2)
2016 (2)
2011 (2)
2026 (1)
2024 (1)
2021 (1)
2017 (1)
2015 (1)
2014 (1)
2012 (1)

Lab affiliation

Center for Proteomics and Metabolomics, Leiden University Medical Center (1)
Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, N0. 1037 Luoyudong Road, Hongshan District, Wuhan 430074 (1)
Head Proteomics Group, Leiden University Medical Center, Center for Proteomics and Metabolomics, PO Box 9600, Postal zone P1-Q, 2300 RC Leiden, The Netherlands (1)
Head, Chair Plant Biotechnology Faculty of Biology University of Freiburg Schaenzlestrasse 1 D-79104 Freiburg Germany (1)
The University of Sydney (1)
Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, Bordeaux Proteome, F-33600 Pessac, France (1)

Publication date

2025 (9)
2024 (8)
2023 (7)
2021 (5)
2022 (4)
2026 (3)
2020 (3)
2019 (3)
2015 (2)
2018 (1)

Tags

xref:PubMed:42667654 (1)

Previous page
1 / 9
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 9
Next page

Sort by:

Relevance

Page size

Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma.

Not available

S-EPMC5868155 | biostudies-literature

Diagnostic Potential of Plasma IgG N-glycans in Discriminating Thyroid Cancer from Benign Thyroid Nodules and Healthy Controls

BACKGROUND: Novel biomarkers are urgently needed to distinguish between benign and malignant thyroid nodules and detect thyroid cancer in the early stage. The associations between serum IgG N-glycosylation and thyroid cancer risk have been revealed. We aimed to explore the potent...

2021-09-01 | MTBLS2935 | MetaboLights

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities.

Not available

S-EPMC5539844 | biostudies-literature

Endolysins of Bacillus anthracis bacteriophages recognize unique carbohydrate epitopes of vegetative cell wall polysaccharides with high affinity and selectivity.

Not available

S-EPMC3489029 | biostudies-literature

4-(2,5-Dimethyl-1H-pyrrol-1-yl)-N-(2,5-dioxopyrrolidin-1-yl) benzamide improves monoclonal antibody production in a Chinese hamster ovary cell culture.

Not available

S-EPMC8061942 | biostudies-literature

Glycosylation of plasma IgG in colorectal cancer prognosis.

Not available

S-EPMC4908421 | biostudies-literature

microRNA-630 regulates underglycosylated IgA1 production in the tonsils by targeting TLR4 in IgA nephropathy

IgA nephropathy (IgAN) is the most common primary glomerular disease. The characteristic pathology involves immune complexes formed by the deposition of IgA1 and underglycosylated IgA1 aggregates in the mesangial area, which may be accompanied by the deposition of IgG and/or IgM and complement compo...

ORGANISM(S): Homo sapiens

2020-10-07 | GSE159123 | GEO

B Cell Mechanisms Underlie IgG Glycan Alterations in Obesity

The glycosylation of B cell-derived IgG is altered in the setting of obesity, and it contributes to obesity-related insulin resistance. With obesity in both humans and mice a key glycan on the Fc region of IgG is deficient in galactose and in the terminal sialic acid that is linked to galactose. How...

ORGANISM(S): Homo sapiens

2026-09-23 | GSE270270 | GEO

Strain-promoted alkyne-azide cycloadditions (SPAAC) reveal new features of glycoconjugate biosynthesis.

Not available

S-EPMC3151320 | biostudies-literature

IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis.

Not available

S-EPMC6567531 | biostudies-literature

Previous page
1 / 9
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 9
Next page

Sort by:

Relevance

Page size

81 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Metabolite Name

First Public Date

Release Date

Lab affiliation

Publication date

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets